CANCER: Erlotinib-bevacizumab combo beats bevacizumab alone CMA surprised by motion seeking to cap private fees at public levelsOut-of-the-blue proposal from NWT physician sparks lively debate CANCER: Second-line chemotherapy patients benefit from vandetanib Drop of 21% in risk of disease progression seen after 13-month followup Finding balance through karate Achieving skills for international-calibre competition has helped Dr. Maitreyi Raman truly know herself The view from Marketplace NACDS event offers ‘sneak peek’ at hot new products Canada's best drugstore teams Ask the Expert: Diabetes HealthAchieve2009 registration opens Canada’s largest healthcare event Economic woes raise health fears CMA releases ninth annual “National Report Card” Some' allocation change needed: B.C. specialist chief But Society of Specialist Physicians and Surgeons council rejected dropping unanimity requirement First Previous 395 396 397 398 399 Next Last
